Emergency department visits
ED visits for three acute life-threatening conditions declined significantly in the 10 weeks after the U.S. declared a national emergency over COVID-19, relative to the 10 weeks before the … Read More
ED visits for three acute life-threatening conditions declined significantly in the 10 weeks after the U.S. declared a national emergency over COVID-19, relative to the 10 weeks before the … Read More
Population lockdowns should last for at least 60 days to limit the spread of COVID-19 and help prevent or delay a second, larger wave of infections, according to a … Read More
A study in Heart Rhythm lends insight into risks for arrhythmias in COVID-19 patients. Among 700 patients (over 70% Black) admitted to one Pennsylvania hospital, 53 arrhythmic events occurred: 9 cardiac … Read More
We present the case of a psychotic patient whose delusional thought content was focused on COVID-19 and who subsequently developed behavioral disturbances that resulted in severe ocular damage. To … Read More
The monoclonal antibody tocilizumab showed mixed results in treating COVID-19 in a small, retrospective study in EClinicalMedicine. Researchers examined roughly 50 patients admitted to one hospital for COVID-19 in March … Read More
In the Baltimore/Washington, D.C. area, the Latino community has been disproportionately affected by COVID-19, according to a JAMA study. Among 38,000 high-risk or symptomatic people who were tested for SARS-CoV-2 in … Read More
Infected people who are asymptomatic develop a weaker immune response than people who have symptoms, and the response may not be long-lasting, suggests a study in Nature Medicine. Researchers studied … Read More
A clinical trial to evaluate the safety and effectiveness of hydroxychloroquine for the treatment of adults hospitalized with coronavirus disease 2019 (COVID-19) has been stopped by the National Institutes … Read More
Development of a safe, effective COVID-19 vaccine is one of the most pressing current public health imperatives. Adenoviruses have been used safely as vectors for vaccination in humans, although … Read More
The monoclonal antibody mavrilimumab, an investigational treatment that’s been studied for rheumatoid arthritis, is associated with improved clinical outcomes among patients with severe COVID-19 in Italy, suggests a small … Read More